PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Nov-2022 Protein Expression Market - How The Market Will Witness Substantial Growth In The Upcoming Years Markets and Markets
08-Nov-2022 Humana Prices $1.25 Billion Debt Offering Businesswire
08-Nov-2022 Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order Businesswire
08-Nov-2022 AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase Businesswire
08-Nov-2022 Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting Businesswire
08-Nov-2022 Marinus Pharmaceuticals Announces Proposed Public Offering Businesswire
08-Nov-2022 Athersys, Inc. Announces Proposed Public Offering Businesswire
08-Nov-2022 Fabrinet Announces First Quarter Fiscal Year 2023 Financial Results Businesswire
08-Nov-2022 Invacare Reports Results for Third Quarter 2022 Businesswire
08-Nov-2022 CVD Equipment Corporation to Announce 2022 Third Quarter Results Businesswire
08-Nov-2022 NanoString Technologies Releases Operating Results for Third Quarter of 2022 Businesswire
08-Nov-2022 Xencor Reports Third Quarter 2022 Financial Results Businesswire
08-Nov-2022 Ligand Reports Third Quarter 2022 Financial Results Businesswire
08-Nov-2022 Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results Businesswire
07-Nov-2022 Merck, Synergis e IPS apresentam gestão de documentos de engenharia para conformidade e validação simplificadas Businesswire
07-Nov-2022 Merck, Synergis e IPS presentan la gestión de documentos de ingeniería para simplificar el cumplimiento y la validación Businesswire
07-Nov-2022 Merck, Synergis et IPS présentent la gestion des documents d'ingénierie pour simplifier les processus de conformité et de validation Businesswire
07-Nov-2022 Anumana Acquires NeuTrace, Establishing a Comprehensive Electrophysiology Deep-Learning Development Platform and Product Pipeline Businesswire
07-Nov-2022 MedinCell announces the initiation of Phase 3 study of F14 (mdc-CWM), a therapeutic first-in-class that aims to provide weeks of localized pain relief after Total Knee Replacement Businesswire
07-Nov-2022 Safety Management Group To Exhibit At IP Utility Safety Conference & Expo Businesswire